Our 3rd Annual AIM for the CURE Melanoma Walk & Fun Run is scheduled on Saturday, May 12th at North Park. Proceeds support melanoma research at UPMC Hillman Cancer Center. We hope that you will join us to support this event and help us in our fight to eliminate melanoma, the most life-threatening form of skin cancer.
The urgency of melanoma research is supported by the following facts:
• One person dies every 54 minutes from melanoma.
• Pediatric melanoma has tripled in the last 10 years.
• Melanoma is the 2nd most common type of cancer for those under 30 years of age.
• 75% of all skin cancer deaths are from melanoma.
• Melanoma is the only cancer that can metastasize to all major organs.
Your support will help advance innovative research, and new and more promising personalized treatment approaches for the future.
UPMC Hillman Cancer Center is one of four leading melanoma research centers in the U.S. that have laid the groundwork for a tissue bank consortium, which will provide the most basic of tools – primary tissue to be used in research. The tissue bank will be a critical resource for melanoma researchers to advance innovative and novel new treatment options to reverse the progress of this cancer. UPMC Hillman Cancer Center has undertaken melanoma screening and early detection that is novel in the US and the world. 100% of the net proceeds from this event will support the Melanoma Program and tissue bank – benefiting those impacted by melanoma locally, regionally and nationally.
AIM at Melanoma is the largest international melanoma foundation globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education of patients, primary care doctors and specialists as well as patient and caregiver support. The Woiner Foundation is proud to partner with AIM at Melanoma in their common mission to promote awareness and to fund melanoma research.
We would appreciate your consideration of support and invite you to join us in our unwavering battle against melanoma. TOGETHER, we will continue to make a difference in the lives of individuals suffering from this deadly cancer and their families!
John M. Kirkwood, MD
2018 AIM for the Cure Honorary Chair, Pittsburgh